The global challenge of cervical cancer

Cervical cancer is caused by persistent infection with high-risk Human Papillomavirus (HPV). When detected early, HPV-related changes can be monitored or treated long before cancer develops.

Despite this, cervical cancer remains one of the leading causes of cancer-related death among women globally. Each year, hundreds of thousands of women are diagnosed, many at a stage when treatment is complex, costly, and less effective.

The issue is not a lack of medical knowledge.
It is a failure of screening reach.

Most screening programs rely on clinic-based examinations that require trained healthcare professionals, specialized equipment, and in-person visits.

For many women, these requirements create barriers that programs struggle to overcome:

• Limited access to healthcare facilities

• Time constraints and logistical challenges

• Discomfort with gynecological examinations

• Cultural and social stigma

As a result, large populations remain unscreened or under-screened, even in countries with established screening programs.

Late detection is not a failure of medicine.
It is a failure of delivery.

The burden of cervical cancer falls disproportionately on women in low- and middle-income countries, where screening coverage is limited or inconsistent.

However, non-attendance and under-screening are also persistent challenges in high-income countries. Even where programs exist, participation gaps undermine their effectiveness.

To eliminate cervical cancer, screening must reach women where they are and not only those who can visit a clinic.